GlassScriptPhysician profile
Ramsey Joudeh
NPI 1174819353
$1,933.18
in general payments reported to CMS, 2019-2025
16 companies · $369 in 2025
The $369 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $18.21 · 2021: $206 · 2022: $150 · 2023: $295 · 2024: $619 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,276 · Education: $6.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,275.96 |
| Education | $6.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $978.19 | 2019-2025 | Xifaxan, Trulance |
| Lilly USA, LLC | $433.68 | 2023-2025 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $125.00 | 2021 | |
| Uswm, LLC | $93.68 | 2024 | Lucemyra |
| Abbott Laboratories | $72.60 | 2024-2025 | Freestyle Libre 3 |
| Novo Nordisk INC | $61.08 | 2021-2024 | Rybelsus, Ozempic |
| Inogen, INC. | $38.62 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Gilead Sciences, INC. | $35.08 | 2024 | |
| Abbvie INC. | $29.36 | 2023 | |
| Allergan, INC. | $26.96 | 2021 | |
| Merck Sharp & Dohme LLC | $20.72 | 2024 | Verquvo |
| Mannkind Corporation | $18.21 | 2020 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramsey Joudeh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.